The biotech Merus received the first-ever FDA accelerated approval for a systemic treatment targeting a specific genetic ...
The US Patent and Trademark Office has withdrawn its controversial proposal for a new rule that would make it easier to ...
Wisconsin border in 'America's Dairyland,' Eli Lilly is staking one of its largest-ever manufacturing bets to continue its ...
The cold-blooded shooting death of UnitedHealthcare CEO Brian Thompson on Wednesday sent shockwaves through corporate America ...
The cold-blooded shooting death of UnitedHealthcare CEO Brian Thompson on Wednesday sent shockwaves through corporate America ...
Genmab is licensing a second investigational anti-glycan monoclonal antibody from Scancell as part of an agreement inked ...
Protara Therapeutics' experimental cell therapy TARA-002 showed promising results in bladder cancer patients, with 13 of 18 ...
Amgen is investing $1 billion for a second factory in North Carolina after already allocating more than half a billion ...
Merck’s top medical exec said its recent bet on a VEGF bispecific antibody — one of the hottest areas in R&D — is not a form ...
National Resilience replaces CEO Rahul Singhvi with COO William Marth. Moderna opens mRNA facility in Australia. Reckitt ...
CG Oncology says its immunotherapy candidate that could help patients avoid surgery may deliver lasting responses in a ...
GSK revises deal with Chongqing Zhifei Biological Products, extending Shingrix distribution rights in China through 2034 but ...